141 related articles for article (PubMed ID: 38206908)
1. Protocol of efficacy of bifidobacteria intake on gastrointestinal symptoms in symptomatic type 2 diabetes mellitus patients in abdominis: An open-label, randomized controlled trial (Binary STAR study).
Hashimoto Y; Kobayashi G; Kitagawa N; Okada H; Hamaguchi M; Fukui M
PLoS One; 2024; 19(1):e0295998. PubMed ID: 38206908
[TBL] [Abstract][Full Text] [Related]
2. Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial.
Hata S; Nakajima H; Hashimoto Y; Miyoshi T; Hosomi Y; Okamura T; Majima S; Nakanishi N; Senmaru T; Osaka T; Okada H; Ushigome E; Hamaguchi M; Asano M; Yamazaki M; Fukui M
J Diabetes Investig; 2022 Mar; 13(3):489-500. PubMed ID: 34665938
[TBL] [Abstract][Full Text] [Related]
3. Effect of probiotics,
Hashimoto Y; Nakajima H; Hata S; Miyoshi T; Hosomi Y; Majima S; Nakanishi N; Senmaru T; Osaka T; Okada H; Ushigome E; Hamaguchi M; Asano M; Yamazaki M; Fukui M
J Clin Biochem Nutr; 2020 Nov; 67(3):223-227. PubMed ID: 33293761
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of
Fuyuki A; Higurashi T; Kessoku T; Ashikari K; Yoshihara T; Misawa N; Iwaki M; Kobayashi T; Ohkubo H; Yoneda M; Usuda H; Wada K; Nakajima A
Biosci Microbiota Food Health; 2021; 40(2):105-114. PubMed ID: 33996367
[TBL] [Abstract][Full Text] [Related]
5. Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Makizaki Y; Uemoto T; Yokota H; Yamamoto M; Tanaka Y; Ohno H
PLoS One; 2021; 16(3):e0248584. PubMed ID: 33750988
[TBL] [Abstract][Full Text] [Related]
6. Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.
Makizaki Y; Maeda A; Oikawa Y; Tamura S; Tanaka Y; Nakajima S; Ohno H; Yamamura H
Microbiol Immunol; 2019 Dec; 63(12):481-486. PubMed ID: 31544979
[TBL] [Abstract][Full Text] [Related]
7. Effect of probiotics on digestibility and immunity in infants: A study protocol for a randomized controlled trial.
Xiao L; Ding G; Ding Y; Deng C; Ze X; Chen L; Zhang Y; Song L; Yan H; Liu F; Ben X
Medicine (Baltimore); 2017 Apr; 96(14):e5953. PubMed ID: 28383398
[TBL] [Abstract][Full Text] [Related]
8. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.
Lai H; Li Y; He Y; Chen F; Mi B; Li J; Xie J; Ma G; Yang J; Xu K; Liao X; Yin Y; Liang J; Kong L; Wang X; Li Z; Shen Y; Dang S; Zhang L; Wu Q; Zeng L; Shi L; Zhang X; Tian T; Liu X
Gut Microbes; 2023; 15(1):2197837. PubMed ID: 37078654
[TBL] [Abstract][Full Text] [Related]
9. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors.
Kawahara T; Makizaki Y; Oikawa Y; Tanaka Y; Maeda A; Shimakawa M; Komoto S; Moriguchi K; Ohno H; Taniguchi K
PLoS One; 2017; 12(3):e0173979. PubMed ID: 28346473
[TBL] [Abstract][Full Text] [Related]
12. Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial.
Martoni CJ; Evans M; Chow CT; Chan LS; Leyer G
J Dig Dis; 2019 Sep; 20(9):435-446. PubMed ID: 31271261
[TBL] [Abstract][Full Text] [Related]
13. The effect of probiotics on functional constipation in adults: A randomized, double-blind controlled trial.
Mitelmão FCR; Häckel K; Bergamaschi CC; Gerenutti M; Silva MT; Balcão VM; Vila MMDC
Medicine (Baltimore); 2022 Oct; 101(43):e31185. PubMed ID: 36316826
[TBL] [Abstract][Full Text] [Related]
14. The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.
Alyousif Z; Miller JL; Sandoval MY; MacPherson CW; Nagulesapillai V; Dahl WJ
Trials; 2018 Apr; 19(1):256. PubMed ID: 29703235
[TBL] [Abstract][Full Text] [Related]
15. Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study.
Tabbers MM; de Milliano I; Roseboom MG; Benninga MA
Nutr J; 2011 Feb; 10():19. PubMed ID: 21345213
[TBL] [Abstract][Full Text] [Related]
16. Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.
Alyousif Z; Miller JL; Auger J; Sandoval M; Piano A; Tompkins TA; Dahl WJ
Mol Genet Genomic Med; 2020 Dec; 8(12):e1535. PubMed ID: 33103385
[TBL] [Abstract][Full Text] [Related]
17. A randomised, double-blind, placebo-controlled trial of
Wang L; Wang L; Tian P; Wang B; Cui S; Zhao J; Zhang H; Qian L; Wang Q; Chen W; Wang G
Food Funct; 2022 Feb; 13(3):1628-1640. PubMed ID: 35079761
[TBL] [Abstract][Full Text] [Related]
18. Alleviation of low-fiber diet-induced constipation by probiotic
Makizaki Y; Maeda A; Oikawa Y; Tamura S; Tanaka Y; Nakajima S; Yamamura H
Biosci Microbiota Food Health; 2019; 38(2):49-53. PubMed ID: 31106107
[TBL] [Abstract][Full Text] [Related]
19. Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in healthy adults: A double-blind, randomized, placebo-controlled study.
Gomi A; Yamaji K; Watanabe O; Yoshioka M; Miyazaki K; Iwama Y; Urita Y
J Dairy Sci; 2018 Jun; 101(6):4830-4841. PubMed ID: 29573807
[TBL] [Abstract][Full Text] [Related]
20. [An efficacy and safety study of bifidobacterium tetragenous viable bacteria tablets in the treatment of constipation in patients with type 2 diabetes mellitus].
Yuan T; Zhao WG; Cao Y; Li Q; Yao MX; Hao XX; Yu H; Jiang CE; Wang HF; Wang SP; Wei XB; Qiu W
Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):252-257. PubMed ID: 29614582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
